JUDITH HALL: Open Payments
NPI 1992806178 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 13 payments from 8 companies in 2025. Trend: 2023 $780 · 2024 $734 · 2025 $294
Food & beverage: $277Education: $17
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| OPKO Pharmaceuticals, LLC | 1 | $17 |
Products named: EVENITY, FARXIGA, TAVNEOS, ULTOMIRIS, JARDIANCE, MOUNJARO, Kerendia, KRYSTEXXA.
Industry payments across CA — which companies pay providers there.
